share_log

Johnson & Johnson | 4: Statement of changes in beneficial ownership of securities-Officer Schmid Timothy

SEC announcement ·  Feb 21 07:00
Summary by Futu AI
Timothy Schmid, EVP, WW Chair, MedTech at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. As a result, the impact of this event on Schmid's holdings in Johnson & Johnson remains unclear.
Timothy Schmid, EVP, WW Chair, MedTech at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. As a result, the impact of this event on Schmid's holdings in Johnson & Johnson remains unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.